| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/11/2000 | US6048854 2,3-diaminopropionic acid derivative |
| 04/08/2000 | CA2285120A1 Heterocycles |
| 04/06/2000 | WO2000018735A1 2-substituted heterocyclic sulfonamides |
| 04/06/2000 | WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 04/06/2000 | WO2000018391A1 Drugs for improving vesical excretory strength |
| 04/06/2000 | WO2000018369A1 Iontophoretic devices comprising piperidin derivatives |
| 04/06/2000 | WO2000018361A2 Method of treating hair loss using sulfonamides |
| 04/06/2000 | WO2000018358A2 Method of treating hair loss using ketoamides |
| 04/06/2000 | WO2000001671A3 Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 04/06/2000 | WO1999061013A3 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| 04/06/2000 | CA2344894A1 Agents for improving excretory potency of urinary bladder |
| 04/05/2000 | EP0990645A1 Novel sulfonamide derivatives |
| 04/05/2000 | EP0990439A1 Bisaryl compounds and cancer remedies containing the same |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 04/05/2000 | EP0844825A4 Insecticidal n-(substituted arylmethyl)-4- bis(substituted phenyl or pyridyl)methyl]piperidines |
| 04/05/2000 | CN1249743A Arylsulfonylamino hydroxamic acid derivs |
| 04/05/2000 | CN1249685A Use of levobupivacaine or ropivacaine in treating migraine |
| 04/05/2000 | CN1051074C Use of isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides for preparing medicine |
| 04/04/2000 | US6046338 Separation of the enantiomers of amlodipine via their diastereomeric tartrates |
| 04/04/2000 | US6046337 Process for the preparation of a dihydropyridine derivative |
| 04/04/2000 | US6046261 Stabilizer for organic material having excellent blooming resistance |
| 04/04/2000 | US6046215 A piperidinylbenzothiophenes useful for trating brain disorders |
| 04/04/2000 | US6046214 Useful in treatment and/or prevention of diabetes, and especially non-insulin dependent diabetes (niddm or type 2 diabetes) including overnight or meal treatment and treatment or prevention of longterm complications, such as retinopathy |
| 04/04/2000 | US6046213 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/04/2000 | CA1340943C Azacyclic compounds and their preparation and use |
| 03/30/2000 | WO2000017162A1 Novel thiol derivatives, process for producing the same and utilization thereof |
| 03/30/2000 | WO2000017158A1 Urokinase inhibitors |
| 03/30/2000 | WO2000016603A2 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2344412A1 Thiol compound, their production and use |
| 03/30/2000 | CA2344376A1 Bridged heterocyclic derivatives |
| 03/29/2000 | EP0989121A1 Substituted benzamides and their use as immunomodulators |
| 03/29/2000 | EP0989120A1 Reagents for assaying central local acetylcholinesterase activity |
| 03/29/2000 | EP0988300A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 03/29/2000 | EP0988273A1 Polymerization inhibition of acrylates using blends of nitroxides |
| 03/29/2000 | EP0988263A1 Process for the production of radioiodinated neuroreceptor agents |
| 03/29/2000 | CN1248915A Medicament against infertility and for increasing fertility |
| 03/29/2000 | CN1248439A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system |
| 03/29/2000 | CN1050832C Process for preparing fibrinogen receptor antagonists |
| 03/28/2000 | US6043403 Process for the preparation of cyclopentadienyl compounds and compounds obtained therefrom |
| 03/28/2000 | US6043284 Anti-atherosclerotic diaryl compounds |
| 03/28/2000 | US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes |
| 03/28/2000 | US6043261 Pyrrolodino imidines useful as nitric oxide synthase inhibitors |
| 03/28/2000 | US6043255 Muscarinic antagonists |
| 03/28/2000 | US6043251 Treating muscular and nervous system disorders; including an effective amount of 2-amino-6-trifluoromethoxybenzothiazole |
| 03/28/2000 | US6043239 Heterocyclic compounds |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/28/2000 | CA2056662C Naphthoic acid derivative |
| 03/24/2000 | CA2283021A1 Substituted benzamides |
| 03/23/2000 | WO2000015613A1 Method of making tertiary hindered amines |
| 03/23/2000 | WO2000015610A1 The preparation of n-substituted-hydroxycycloalkylamine derivatives |
| 03/23/2000 | WO2000008013A3 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | CA2343837A1 The preparation of n-substituted-hydroxycycloalkylamine derivatives |
| 03/22/2000 | EP0986551A1 Sulfonamide derivatives, their production and use |
| 03/22/2000 | EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 03/22/2000 | EP0986395A1 Peptide parathyroid hormone analogs |
| 03/22/2000 | EP0986393A1 The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
| 03/22/2000 | EP0986389A1 Novel process |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/22/2000 | EP0889918B1 In situ block copolymer formation during polymerization of a vinyl aromatic monomer |
| 03/22/2000 | EP0804537B1 Cleaning process and composition |
| 03/22/2000 | CN1248162A Topical pharmaceutical composition comprising cholinergic agent or calcium channel blocker |
| 03/21/2000 | US6040449 Useful for forming fluorine containing 1,4-disubstituted piperidine derivatives, useful as antagonist for muscarinic m3 receptors and less side effect |
| 03/21/2000 | US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal |
| 03/21/2000 | US6040318 Treating insulin resistant non-insulin-dependent diabetes mellitus and ageing-associated obesity, neurogenic inflammation associated with neuropathy or rheumatoid arthritis |
| 03/21/2000 | US6040317 Sulfonamide fibrinogen receptor antagonists |
| 03/21/2000 | US6040316 Tachykinin antagonists treating pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorders, inflammatory diseases, gastrointestinal disorders, vascular disorders, and neuropathological disorders |
| 03/21/2000 | US6039939 N-acyl-hydroxyamino acid esters and their use |
| 03/16/2000 | WO2000014176A1 Piperidine antioxidants and compositions therewith for preventing the fading of artificial hair dye |
| 03/16/2000 | WO2000014083A1 SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
| 03/16/2000 | WO2000014067A1 Piperidine derivatives |
| 03/16/2000 | WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 03/16/2000 | WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 03/16/2000 | WO2000013707A1 Preventives/remedies for multiple organ failure |
| 03/16/2000 | WO2000005206A8 Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
| 03/16/2000 | WO1999064047A9 Novel antiviral compounds |
| 03/16/2000 | WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/16/2000 | WO1999059499A3 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders |
| 03/16/2000 | CA2343168A1 Piperidine derivatives |
| 03/16/2000 | CA2342898A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 03/16/2000 | CA2342796A1 Preventives/remedies for multiple organ failure |
| 03/15/2000 | EP0985667A1 Novel dihydropyridine derivative |
| 03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/15/2000 | EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity |
| 03/15/2000 | EP0984778A1 Neuropeptide-y ligands |
| 03/15/2000 | EP0984777A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia |
| 03/15/2000 | CN1247531A Arylsulfonyl hydroxamic acid derivatives |
| 03/14/2000 | US6037500 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands |
| 03/14/2000 | US6037353 Administering terfenadine acid derivative; cardiac side effect reduction |
| 03/14/2000 | US6037352 N-substituted piperidine derivatives; treating alzheimer*s disease, nervous system disorders; acetylcholinesterase inhibitors |
| 03/14/2000 | US6037351 Method of inhibiting hepatitis B virus |
| 03/14/2000 | US6037343 Fibrinogen receptor antagonists |
| 03/09/2000 | WO2000012745A1 Method for preparing (2r)-piperidine derivatives |
| 03/09/2000 | WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 03/09/2000 | WO2000012476A1 Processes for preparing 2-piperidineethanol compounds |
| 03/09/2000 | WO2000012090A1 THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS |
| 03/09/2000 | WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 03/09/2000 | WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 03/09/2000 | WO1999062893A3 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |